Impact of financial burden, resulting from prescription co-payments, on antihypertensive medication adherence in an older publically insured population.
Paul DillonSusan M SmithPaul GallagherGráinne CousinsPublished in: BMC public health (2018)
This co-payment represents a financial barrier to antihypertensive adherence for many older Irish publically insured patients. The negative impact to adherence will potentially increase the risk of adverse outcomes, such as stroke, and increase long-term healthcare costs.
Keyphrases
- healthcare
- blood pressure
- end stage renal disease
- physical activity
- ejection fraction
- community dwelling
- newly diagnosed
- chronic kidney disease
- middle aged
- affordable care act
- peritoneal dialysis
- type diabetes
- glycemic control
- metabolic syndrome
- risk factors
- young adults
- health insurance
- skeletal muscle
- insulin resistance
- patient reported outcomes
- social media